Zhaoyan Pharmaceutical announced that Zhou Zhiwen, the controlling shareholder and actual controller, held 74.726 million shares, accounting for 9.9704% of the total share capital. It plans to reduce its holdings by no more than 14.98 million shares through centralized bidding or bulk trading on the Shanghai Stock Exchange within 3 months after 15 trading days from the announcement date, not more than 20.0466% of its shares and no more than 1.99873% of the company's total share capital. The holdings reduction period is expected to be from January 22, 2026 to April 21, 2026. The source of shares is pre-IPO shares and additional shares from the Capital Provident Fund. The reason for the holdings reduction is due to own capital requirements.

Zhaoyan Pharmaceutical announced that Zhou Zhiwen, the controlling shareholder and actual controller, held 74.726 million shares, accounting for 9.9704% of the total share capital. It plans to reduce its holdings by no more than 14.98 million shares through centralized bidding or bulk trading on the Shanghai Stock Exchange within 3 months after 15 trading days from the announcement date, not more than 20.0466% of its shares and no more than 1.99873% of the company's total share capital. The holdings reduction period is expected to be from January 22, 2026 to April 21, 2026. The source of shares is pre-IPO shares and additional shares from the Capital Provident Fund. The reason for the holdings reduction is due to own capital requirements.